Last reviewed · How we verify

NCT04322994

THRIVE Use in Pediatric Populations- Multi Site

Completed NA Results posted Last updated 27 March 2025
What this trial tests

NA trial testing Transnasal Humidified Rapid-Insufflation Ventilatory Echange in Oxygen Deficiency in 175 participants. Completed in 19 January 2024.

Timeline
21 October 2020
Primary endpoint
19 January 2024
19 January 2024

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment175
Start date21 October 2020
Primary completion19 January 2024
Estimated completion19 January 2024
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Under 18, any sex, with Oxygen Deficiency or Desaturation of Blood. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index Primary · Duration of surgery or procedure, which is generally less than 2 hours

Oxygen desaturation index is defined as a 4% decrease in saturation from a 120 second rolling mean for greater than 10 seconds; data were recorded every 2 seconds while the procedure was being performed.

Any event
GroupValue95% CI
Control18
High-flow Nasal Cannula11
1 event
GroupValue95% CI
Control13
High-flow Nasal Cannula9
2+ events
GroupValue95% CI
Control5
High-flow Nasal Cannula2
Number of Participants With Desaturations <90% Primary · Duration of surgery or procedure, which is generally less than 2 hours

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed.

Any event
GroupValue95% CI
Control17
High-flow Nasal Cannula11
1 event
GroupValue95% CI
Control8
High-flow Nasal Cannula9
2+ events
GroupValue95% CI
Control9
High-flow Nasal Cannula2
Number of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation Primary · Duration of surgery or procedure, which is generally less than 2 hours

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed. Participants who experienced both a fall below 90% O2 and a 4% drop below baseline saturation are reported as having more than 1 event.

Any event
GroupValue95% CI
Control19
High-flow Nasal Cannula13
1 event
GroupValue95% CI
Control3
High-flow Nasal Cannula3
2+ events
GroupValue95% CI
Control16
High-flow Nasal Cannula10
Time-normalized Area Under Curve (AUC) of Desaturations <90% Secondary · Duration of surgery or procedure, which is generally less than 2 hours

Duration of oxygen desaturation less than 90% as measured by pulse oximetry by second by analyzing area under curve less than 90% (in those participants who experienced desaturation less than 90%), normalized as area under the curve / total time.

GroupValue95% CI
Control0.3± 0.91
High-flow Nasal Cannula0.28± 1.19
Number of Participants With Surgical Interruptions Due to Desaturation Secondary · Duration of surgery or procedure, which is generally less than 2 hours

Number of surgical interruptions due to desaturation defined by a pause in surgical procedures due to need to provide airway intervention to improve patient's oxygen saturation, normalized to case length. Airway interventions may include jaw thrust, bag mask ventilation, and/or endotracheal intubations.

Any event
GroupValue95% CI
Control14
High-flow Nasal Cannula7
1 event
GroupValue95% CI
Control11
High-flow Nasal Cannula5
2+ events
GroupValue95% CI
Control3
High-flow Nasal Cannula2
Minimum Oxygen Saturation as a Measure of Desaturation Severity Secondary · Duration of surgery or procedure by second, which is generally less than 2 hours

Number of participants categorized by lowest oxygen saturation level during surgery (nadir). Lower saturation levels correspond to a lower level of oxygen in red blood cells.

0-50% O2 saturation
GroupValue95% CI
Control2
High-flow Nasal Cannula2
50-70% O2 saturation
GroupValue95% CI
Control3
High-flow Nasal Cannula2
70-90% O2 saturation
GroupValue95% CI
Control12
High-flow Nasal Cannula7
90-100% O2 saturation
GroupValue95% CI
Control54
High-flow Nasal Cannula62

Sponsor's own description

THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Oxygen Deficiency

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04322994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing